Beth Israel Dermatology Foundation Inc Boston, MA - 02215

Beth Israel Dermatology Foundation Inc is categorized under Synagogues in Boston, MA and active since 2011.

Beth Israel Dermatology Foundation Inc was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Synagogues business, which does work in the B2C market, and is classified as a Synagogues, under code number 813110 by the NAICS.

If you are seeking more information, feel free to contact Robert Stern at the company’s single location by writing to 330 Brookline Avenue, Boston, Massachusetts MA 02215 or by phoning (617) 667-4995. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Beth Israel Dermatology Foundation Inc
Contact Person: Robert Stern
Address: 330 Brookline Avenue, Boston, Massachusetts 02215
Phone Number: (617) 667-4995
Annual Revenue (USD): $50.000 to $99.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Synagogues
SIC Code: 8661
NAICS Code: 813110
Share This Business:

Beth Israel Dermatology Foundation Inc was started in 2011 to provide professional Synagogues under the SIC code 8661 and NAICS code 813110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Robert Stern for inquiries that concern Beth Israel Dermatology Foundation Inc by calling the company number (617) 667-4995, as your correspondence is most welcome. Additionally, the physical location of the single location of Beth Israel Dermatology Foundation Inc can be found at the coordinates 42.340894,-71.104931 as well as the street address 330 Brookline Avenue in Boston, Massachusetts 02215.

For its online presence, you may visit Beth Israel Dermatology Foundation Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.